23andMe's breast cancer test may create false sense of security
7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?
7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?
6 March 2018
The prestigious annual Brain prize has gone to work on Alzheimer's disease. That's fine, but the failure to find new treatments is worrying, says Jacqui Wise